Abstract
Pathological gambling is a prevalent disorder that is gaining attention from patients, clinicians and policy makers. Aetiological factors that have been related to pathological gambling include: (i) abnormalities in the serotonergic, dopaminergic and noradrenergic systems; (ii) cognitive distortions; and (iii) a reinforcement of the gambling activity by either episodic gains or the excitement that accompanies gambling. Male gender, urban residence, lower income and the presence of a comorbid psychiatric disorder (particularly substance abuse) appear to constitute risk factors for the presence of the disorder.
A number of treatments have been suggested as potentially effective: Gamblers Anonymous, behavioural therapy, manualised cognitive therapy and several medications. At present, only manualised cognitive therapy and the selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor fluvoxamine have shown efficacy in systematic (albeit small) studies. However, much research remains to be done to better understand the psychophysiology of pathological gambling, to firmly demonstrate the efficacy of the different proposed treatment approaches, and to establish criteria for treatment selection for individual patients.
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders. 3rd ed. Washington, DC: AmericanPsychiatric Press, 1980
Ciarrocchi J, Richardson R. Profile of compulsive gamblers intreatment: update and comparisons. J Gambling Behav 1989;5: 53–65
Petry NM, Armentano C. Prevalence, assessment, and treatment of pathological gambling: a review. Psychiatr Serv 1999; 50:1021–7
Shaffer HJ, Hall MN, Vanderbilt J. Estimating the prevalenceof disordered gambling behavior in the United States and Canada: a meta-analysis [report]. Boston (MA): Harvard University,1997
Lesieur HR, Rosenthal RJ. Pathological gambling: a review of the literature. J Gambling Stud 1991; 7: 5–40
Shaffer HJ, Hall MN, Vanderbilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: aresearch synthesis. Am J Public Health 1999; 89: 1369–76
Volberg RA. The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 1994; 84(2): 237–41
Lesieur HR, Blume SB, Zoppa RM. Alcoholism, drug abuse and gambling. Alcohol Clin Exp Res 1986; 10(1): 33–8
Browne BA, Brown DJ. Predictors of lottery gambling among American college students. J Soc Psychol 1994; 134(3): 339–47
Zeitlin H. Children with alcohol misusing parents. Br Med Bull 1994; 50(1): 139–51
Lesieur HR, Cross J, Frank M, et al. Gambling and pathological gambling among university students. Addict Behav 1991; 16: 517–27
Volberg RA, Abbott MW. Lifetime prevalence estimates of pathological gambling in New Zealand. Int J Epidemiol 1994; 23: 976–83
Freud S. Dostoevsky and parricide 1928. In: Strachey J, editor and translator. The complete psychological works of Sigmund Freud. Standard edition. Vol. XIX. London: The Hogart Press, 1981: 157–170
Bergler E. The psychology of gambling. New York (NY): International University Press, 1958
Rosenthal RJ. The psychodynamics of pathological gambling: a review of the literature. In: Galski T, editor. The handbook of pathological gambling. Springfield (IL): Charles C. Thomas Publisher, Ltd, 1987
Morán E. Clinical and social aspects of risk-taking. Proc R Soc Med 1970; 63: 1273–5
Brown R. Arousal and sensation-seeking components in the general explanation of gambling and gambling addictions. Int J Addict 1986; 21: 1001–16
McConaghy N, Armstrong MS, Blaszcynski AP, et al. Behavior completion versus stimulus control in compulsive gambling. Implications for behavioral assessment. Behav Modif 1988; 12(3): 371–84
Ladouceur R, Mayrand M, Tourigny Y Risk taking behavior in gamblers and nongamblers during prolonged exposure. J Gambling Behav 1987; 3: 115–22
Moreno I, Saiz-Ruiz J, Lopez-Ibor Aliño JJ. Serotonin and gambling dependence. Human Psychopharmacol 1991; 6: S9–12
DeCaria CM, Hollander E, Grossman R, et al. Diagnosis, neurobiology and treatment of pathological gambling. J Clin Psychiatry 1996; 57 Suppl. 8: 80–4
Pérez de Castro I, Ibáñez A, Sáiz-Ruiz J, et al. Genetic contribution to pathological gambling: association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected males. Pharmacogenetics 1999; 9: 397–400
Blanco C, Oresanz-Muñoz L, Bianco-Jerez C, et al. Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 1996; 153: 119–21
Ibáñez A, Pérez de Castro I, Fernández-Piqueras J, et al. Genetic association study between pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 2000; 5: 105–9
Roy A, Adinoff B, Roehrich L et al. Pathological gambling: a psychobiological study. Arch Gen Psychiatry 1988; 45: 369–73
Roy A, Dejong J, Linnoila M. Extraversion in pathological gamblers. Arch Gen Psychiatry 1989; 46: 679–81
DeCaria C, Hollander E, Nora R, et al. Gambling: biological/ genetic, treatment, government, and gambling concerns: neurobiology of pathological gambling. Presented at the 150th Annual Meeting of the American Psychiatric Association (APA): 1997 May 17–22; San Diego (CA)
Bergh C, Eklund T, Sodersten P, et al. Altered dopamine functionin pathological gambling. Psychol Med 1997; 27(2): 473–5
Perez de Castro I, Ibáñez A, Torres P, et al. Genetic associationstudy between pathological gambling and a functional DNA polymorphism at the D4 receptor. Pharmacogenetics 1997; 7: 345–8
Lesieur HR, Blume SB. The South Oaks Gambling Screen(SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144(9): 1184–8
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. ed. Washington, DC: American Psychiatric Press, 1987
Johnson EE, Hamer R, Nora RM, et al. The Lie/Bet Questionnaire for screening pathological gamblers. Psychol Rep 1997; 80: 83–8
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994
World Health Organization. International classification of diseases. 10th ed. Geneva: World Health Organization, 1992
Lesieur HR, Blume SB. Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse and pathological gambling treatment unit using the Addiction SeverityIndex. Br J Addict 1991; 86: 1017–28
DeCaria CM, Hollander E, Begaz T, et al. Reliability and validity of a pathological gambling modification of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS): preliminary findings. Presented at the 12th National Conference on Pathological Gambling: 1998 Jul 13–15; Las Vegas (NV)
Lesieur HR, Heineman M. Pathological gambling among youthfulmultiple substance abusers in a therapeutic community. Br J Addict 1988; 83: 765–71
McCormick RA, Russo AM, Ramirez LF, et al. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984; 142: 215–8
Specker SM, Carlson GA, Christenson GA, et al. Impulse control disorders and attention deficit disorder in pathological gamblers. Ann Clin Psychiatry 1995; 7: 175–9
Bland RC, Newman SC, Orn H, et al. Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 1993; 38: 108–12
Cunningham-Williams RM, Cottler LB, Compton WM, et al. Taking chances: problem gamblers and mental health disorders: results from the St. Louis Epidemiological Catchement Area Study. Am J Public Health 1998; 88: 1093–6
Daghestani AN, Elenz E, Crayton JW. Pathological gambling in hospitalized substance abusing veterans. J Clin Psychiatry 1996; 57(8): 360–3
Taber JI, McCormick RA, Russo AM, et al. Follow-up of pathological gamblers after treatment. Am J Psychiatry 1987; 148: 757–61
Thorson JA, Powell FC, Hilt M. Epidemiology of gambling and depression in an adult sample. Psychol Rep 1994; 74(3): 987–94
Blaszczynski A, McConaghy N, Frankova A. Crime, antisocialpersonality and pathological gambling. Gambling Behav 1989; 5: 137–52
Stewart RM, Brown RIF. An outcome study of gamblers anonymous. Br J Psychiatry 1988; 152: 284–8
Johnson EE, Nora RM. Does spousal participation in GamblersAnonymous benefit compulsive gamblers? Psychol Rep 1992; 71(3 Pt 1): 914
Tepperman JH. The effectiveness of short-term group therapy upon the pathological gambler and wife. J Gambling Behav 1985; 1: 119–30
Blackman S, Simone RV, Thoms DR. The Gamblers Treatment Clinic of St. Vincent’s North Richmond Community Mental Health Center: characteristics of the clients and outcome of treatment. Int J Addict 1989; 24: 29–37
Russo A, Taber J, McCormick R, et al. An outcome study of an inpatient treatment program for pathological gamblers. Hosp Community Psychiatry 1984; 35: 823–7
Bergler E. The psychology of gambling. New York (NY): Hilland Wang, 1957
Bujold A, Ladouceur R, Sylvain C, et al. Treatment of pathological gamblers: an experimental study. J Behav Ther Exp Psychiatry 1994; 25: 275–82
Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: a controlled study. J Consult Clin Psychol 1997; 65: 727–32
Hollander E, Frenkel M, DeCaria C, et al. Treatment of pathological gambling with clomipramine [letter]. Am J Psychiatry 1992; 149: 710–1
Hollander E, DeCaria C, Mari E, et al. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155: 1781–3
Moskowitz JA. Lithium and lady luck. N Y State J Med 1980; 785–8
Moreno I, Sáiz Ruiz J. Tratamiento de un caso de ludopatía(juego patológico) con sales de litio. In: Cacabelos R, editor.Anuario Psiquiátrico. Barcelona: Prous, 1991: 249–54
Haller R, Hinterhuber H. Treatment of pathological gamblingwith carbamazepine. Pharmacopsychiatry 1994; 27(3): 129
Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998; 59: 159–64
Turón JV, Salgado P, González A, et al. Tratamiento farmacológico del juego patológico. Actas de la XV Reunión de la Sociedad Española de Psiquiatría Biológica: 1990 Nov 4–6; Córdoba, 368-75
Hollander E, DeCaria C, Finkell JN, et al. A randomized double-blind fluvoxamine/placebo cross-over trial in pathological gambling. Biol Psychiatry. In press
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blanco, C., Ibáñez, A., Sáiz-Ruiz, J. et al. Epidemiology, Pathophysiology and Treatment of Pathological Gambling. Mol Diag Ther 13, 397–407 (2000). https://doi.org/10.2165/00023210-200013060-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-200013060-00002